
Opinion|Videos|June 18, 2024
Bridging the Gap: Multidisciplinary Collaboration in Early Breast Cancer Care
The panelists share their concluding thoughts on the importance of collaboration between academic and community practices to achieve the best outcomes for their patients, which includes seeking second opinions and incorporating insights from tumor board discussions.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- When a new eBC product is approved, what is done prior to prepare from an operational standpoint?
- Are there instances when a new eBC product is approved and it’s not worth operationalizing?
- How can academic centers work efficiently with community practices in the management of patients with eBC?
- Scimeca: How might the approval of targeted therapies affect treatment paradigms for eBC?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Is Berberine Nature’s GLP-1?
2
Meeting Patients Where They Are: How Pharmacists Are Helping People Stay on Track With Schizophrenia Treatment
3
Glucodensity Analysis Enhances CGM Accuracy for Detecting Cystic Fibrosis–Related Diabetes
4
Because Ned Said: America’s Growing Pharmacy Deserts Are Leaving Patients High and Dry
5















































































































































































































